The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis

{ 'indexed': { 'date-parts': [[2024, 11, 13]], 'date-time': '2024-11-13T05:16:04Z', 'timestamp': 1731474964395, 'version': '3.28.0'}, 'reference-count': 24, 'publisher': 'Springer Science and Business Media LLC', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2024, 11, 12]], 'date-time': '2024-11-12T00:00:00Z', 'timestamp': 1731369600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc-nd/4.0'}, { 'start': { 'date-parts': [[2024, 11, 12]], 'date-time': '2024-11-12T00:00:00Z', 'timestamp': 1731369600000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc-nd/4.0'}], 'funder': [ { 'name': 'National Clinical Therapy Research in the Specialist Health Services (Klinbeforsk), ' 'Norway'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'DOI': '10.1038/s43856-024-00650-4', 'type': 'journal-article', 'created': { 'date-parts': [[2024, 11, 12]], 'date-time': '2024-11-12T06:37:11Z', 'timestamp': 1731393431000}, 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a ' 'pre-specified exploratory analysis', 'prefix': '10.1038', 'volume': '4', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-5002-0195', 'authenticated-orcid': False, 'given': 'Thale D. J. Hovdun', 'family': 'Patrick-Brown', 'sequence': 'first', 'affiliation': []}, {'given': 'Andreas', 'family': 'Barratt-Due', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-7775-3404', 'authenticated-orcid': False, 'given': 'Marius', 'family': 'Trøseid', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-4009-4032', 'authenticated-orcid': False, 'given': 'Anne Ma', 'family': 'Dyrhol-Riise', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-8085-4932', 'authenticated-orcid': False, 'given': 'Katerina', 'family': 'Nezvalova-Henriksen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Trine', 'family': 'Kåsine', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-0919-836X', 'authenticated-orcid': False, 'given': 'Pål', 'family': 'Aukrust', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-6889-5873', 'authenticated-orcid': False, 'given': 'Inge C.', 'family': 'Olsen', 'sequence': 'additional', 'affiliation': []}, {'name': 'NOR Solidarity consortium', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2024, 11, 12]]}, 'reference': [ { 'key': '650_CR1', 'doi-asserted-by': 'crossref', 'unstructured': 'Huang, C. et al. Clinical features of patients infected with 2019 novel ' 'coronavirus in Wuhan, China. Lancet. 395, 497-506 (2020).', 'DOI': '10.1016/S0140-6736(20)30183-5'}, { 'key': '650_CR2', 'unstructured': 'World Health Organization. Statement on the second meeting of the ' 'International Health Regulations (2005) Emergency Committee regarding ' 'the outbreak of novel coronavirus (2019-nCoV) [Internet]. Geneva, ' 'Switzerland: World Health Organisation (WHO); 2020; 30 January 2020. ' 'Available at ' 'https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).'}, { 'key': '650_CR3', 'doi-asserted-by': 'publisher', 'first-page': '1189', 'DOI': '10.1007/s40121-023-00789-y', 'volume': '12', 'author': 'SM Brown', 'year': '2023', 'unstructured': 'Brown, S. M. et al. Consistent effects of early remdesivir on symptoms ' 'and disease progression across at-risk outpatient subgroups: treatment ' 'effect heterogeneity in PINETREE study. Infect. Dis. Ther. 12, 1189–1203 ' '(2023).', 'journal-title': 'Infect. Dis. Ther.'}, { 'key': '650_CR4', 'doi-asserted-by': 'crossref', 'first-page': '1941', 'DOI': '10.1016/S0140-6736(22)00519-0', 'volume': '399', 'author': 'World Health Organization Solidarity Trial Consortium.', 'year': '2022', 'unstructured': 'World Health Organization Solidarity Trial Consortium. Remdesivir and ' 'three other drugs for hospitalised patients with COVID-19: final results ' 'of the WHO Solidarity randomised trial and updated meta-analyses ' '[published correction appears in Lancet. 2022 Oct 29;400(10362):1512]. ' 'Lancet. 399, 1941–1953 (2022).', 'journal-title': 'Lancet.'}, { 'key': '650_CR5', 'doi-asserted-by': 'publisher', 'first-page': '453', 'DOI': '10.1016/S2213-2600(22)00528-8', 'volume': '11', 'author': 'A Amstutz', 'year': '2023', 'unstructured': 'Amstutz, A. et al. Effects of remdesivir in patients hospitalised with ' 'COVID-19: a systematic review and individual patient data meta-analysis ' 'of randomised controlled trials. Lancet Respir. Med. 11, 453–464 (2023).', 'journal-title': 'Lancet Respir. Med.'}, { 'key': '650_CR6', 'doi-asserted-by': 'publisher', 'first-page': 'm1849', 'DOI': '10.1136/bmj.m1849', 'volume': '369', 'author': 'W Tang', 'year': '2020', 'unstructured': 'Tang, W. et al. Hydroxychloroquine in patients with mainly mild to ' 'moderate coronavirus disease 2019: open label, randomised controlled ' 'trial. BMJ 369, m1849 (2020).', 'journal-title': 'BMJ'}, { 'key': '650_CR7', 'doi-asserted-by': 'crossref', 'first-page': 'e192', 'DOI': '10.1016/S1473-3099(20)30483-7', 'volume': '20', 'author': 'WHO Working Group on the Clinical Characterisation and Management of COVID-19 ' 'infection.', 'year': '2020', 'unstructured': 'WHO Working Group on the Clinical Characterisation and Management of ' 'COVID-19 infection. A minimal common outcome measure set for COVID-19 ' 'clinical research [published correction appears in Lancet Infect Dis. ' '2020 Oct;20(10):e250]. Lancet Infect. Dis. 20, e192–e197 (2020).', 'journal-title': 'Lancet Infect. Dis.'}, { 'key': '650_CR8', 'doi-asserted-by': 'publisher', 'first-page': '1261', 'DOI': '10.7326/M21-0653', 'volume': '174', 'author': 'A Barratt-Due', 'year': '2021', 'unstructured': 'Barratt-Due, A. et al. Evaluation of the effects of remdesivir and ' 'hydroxychloroquine on viral clearance in COVID-19: a randomized trial. ' 'Ann. Intern. Med. 174, 1261–1269 (2021).', 'journal-title': 'Ann. Intern. Med.'}, { 'key': '650_CR9', 'unstructured': 'World Health Organization. A clinical case definition of post COVID-19 ' 'condition by a delphi consensus, Accessed 14 March 2023 (World Health ' 'Organization, 2021).'}, { 'key': '650_CR10', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/ofid/ofae027', 'volume': '11', 'author': 'ZO Demko', 'year': '2024', 'unstructured': 'Demko, Z. O. et al. Two-year longitudinal study reveals that long COVID ' 'symptoms peak and quality of life nadirs at 6-12 months postinfection. ' 'Open Forum Infect. Dis. 11, ofae027 (2024).', 'journal-title': 'Open Forum Infect. Dis.'}, { 'key': '650_CR11', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41598-023-36995-4', 'volume': '13', 'author': 'Y Kim', 'year': '2023', 'unstructured': 'Kim, Y. et al. Long COVID prevalence and impact on quality of life 2 ' 'years after acute COVID-19. Sci Rep 13, 11207 (2023).', 'journal-title': 'Sci Rep'}, { 'key': '650_CR12', 'doi-asserted-by': 'crossref', 'unstructured': 'Sun C., Liu Z., Li S., Wang Y. & Liu G. Impact of Long COVID on ' 'Health-Related Quality of Life Among Patients After Acute COVID-19 ' 'Infection: A Cross-Sectional Study. Inquiry. (2024).', 'DOI': '10.1177/00469580241246461'}, { 'key': '650_CR13', 'doi-asserted-by': 'publisher', 'unstructured': 'Olsen, I. C. & Barrat-Due, A. (2023) Nor-Solidarity: Patient Reported ' 'Outcome Measures paper, OSF. Available at: ' 'https://doi.org/10.17605/OSF.IO/HGRVP (Accessed: 07 October 2024).', 'DOI': '10.17605/OSF.IO/HGRVP'}, { 'key': '650_CR14', 'unstructured': 'CAT Assessment Test. www.catestonline.org. ' 'https://www.catestonline.org.'}, { 'key': '650_CR15', 'unstructured': 'EuroQol. EQ-5D−5L. EuroQol. (2009). ' 'https://euroqol.org/information-and-support/euroqol-instruments/eq-5d-5l/.'}, { 'key': '650_CR16', 'unstructured': 'RAND. 36-Item Short Form Survey from the RAND Medical Outcomes Study. ' 'Rand.org. (2019). ' 'https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form.html.'}, { 'key': '650_CR17', 'unstructured': 'Viedoc - The New Standard in eClinical Data Management | Viedoc. Viedoc. ' '(2023). Accessed 14 August 2024. https://www.viedoc.com.'}, { 'key': '650_CR18', 'doi-asserted-by': 'publisher', 'first-page': '2338', 'DOI': '10.1002/sim.7643', 'volume': '37', 'author': 'DM Tompsett', 'year': '2018', 'unstructured': 'Tompsett, D. M., Leacy, F., Moreno-Betancur, M., Heron, J. & White, I. ' 'R. On the use of the not-at-random fully conditional specification ' '(NARFCS) procedure in practice. Stat. Med. 37, 2338–2353 (2018).', 'journal-title': 'Stat. Med.'}, { 'key': '650_CR19', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41467-022-33825-5', 'volume': '13', 'author': 'OPO Nevalainen', 'year': '2022', 'unstructured': 'Nevalainen, O. P. O. et al. Effect of remdesivir post hospitalization ' 'for COVID-19 infection from the randomized SOLIDARITY Finland trial. Nat ' 'Commun 13, 6152 (2022).', 'journal-title': 'Nat Commun'}, { 'key': '650_CR20', 'doi-asserted-by': 'publisher', 'first-page': '195', 'DOI': '10.1016/S2213-2600(14)70001-3', 'volume': '2', 'author': 'SS Kon', 'year': '2014', 'unstructured': 'Kon, S. S. et al. Minimum clinically important difference for the COPD ' 'Assessment Test: a prospective analysis. Lancet Respir. Med. 2, 195–203 ' '(2014).', 'journal-title': 'Lancet Respir. Med.'}, { 'key': '650_CR21', 'doi-asserted-by': 'publisher', 'first-page': '1813', 'DOI': '10.1056/NEJMoa2007764', 'volume': '383', 'author': 'JH Beigel', 'year': '2020', 'unstructured': 'Beigel, J. H. et al. Remdesivir for the treatment of Covid-19 - final ' 'report. N. Engl. J. Med. 383, 1813–1826 (2020).', 'journal-title': 'N. Engl. J. Med.'}, { 'key': '650_CR22', 'doi-asserted-by': 'publisher', 'first-page': '865', 'DOI': '10.1093/qjmed/hcab297', 'volume': '114', 'author': 'L Boglione', 'year': '2022', 'unstructured': 'Boglione, L. et al. Risk factors and incidence of long-COVID syndrome in ' 'hospitalized patients: does remdesivir have a protective effect? QJM ' '114, 865–871 (2022).', 'journal-title': 'QJM'}, { 'key': '650_CR23', 'doi-asserted-by': 'publisher', 'first-page': '554', 'DOI': '10.1001/jamainternmed.2023.0743', 'volume': '183', 'author': 'Y Xie', 'year': '2023', 'unstructured': 'Xie, Y., Choi, T. & Al-Aly, Z. Association of Treatment With ' 'Nirmatrelvir and the Risk of Post-COVID-19 Condition. JAMA Intern. Med. ' '183, 554–564 (2023).', 'journal-title': 'JAMA Intern. Med.'}, { 'key': '650_CR24', 'doi-asserted-by': 'publisher', 'first-page': '807', 'DOI': '10.7326/M22-3565', 'volume': '176', 'author': 'KL Bajema', 'year': '2023', 'unstructured': 'Bajema, K. L. et al. Effectiveness of COVID-19 treatment with ' 'nirmatrelvir-ritonavir or molnupiravir among U.S. veterans: target trial ' 'emulation studies with one-month and six-month outcomes. Ann. Intern. ' 'Med. 176, 807–816 (2023).', 'journal-title': 'Ann. Intern. Med.'}], 'container-title': 'Communications Medicine', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.nature.com/articles/s43856-024-00650-4.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://www.nature.com/articles/s43856-024-00650-4', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://www.nature.com/articles/s43856-024-00650-4.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 11, 12]], 'date-time': '2024-11-12T07:05:35Z', 'timestamp': 1731395135000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.nature.com/articles/s43856-024-00650-4'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 11, 12]]}, 'references-count': 24, 'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2024, 12]]}}, 'alternative-id': ['650'], 'URL': 'http://dx.doi.org/10.1038/s43856-024-00650-4', 'relation': {}, 'ISSN': ['2730-664X'], 'subject': [], 'container-title-short': 'Commun Med', 'published': {'date-parts': [[2024, 11, 12]]}, 'assertion': [ { 'value': '30 July 2023', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '18 October 2024', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '12 November 2024', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': 'None of the authors declare any competing interests. The formal sponsor, Oslo ' 'University Hospital, was not directly (other than as an employer of the study ' 'group) involved in any of the study stages including study design, data ' 'analysis or manuscript preparation.', 'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Competing interests'}}], 'article-number': '231'}